{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:37:06Z","timestamp":1787168226046,"version":"build-2736575974"},"reference-count":57,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["1U62PS005086"],"award-info":[{"award-number":["1U62PS005086"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:p>Background: Community distribution of naloxone, a medication that reverses opioid overdose, is an effective public health strategy to prevent overdose deaths. However, data are limited on who has naloxone during the current fentanyl wave of the opioid overdose epidemic in the United States. We aim to determine correlates of naloxone ownership among a community sample of people who inject drugs (PWID) from New York City (NYC). Methods: Data were drawn from the National HIV Behavioral Surveillance Study among PWID. Participants were recruited via respondent-driven sampling. Eligible participants completed an interviewer-administered survey. Log-linked Poisson regression was used to determine adjusted prevalence ratios (aPR) and 95% confidence intervals (CIs) current naloxone ownership. Results: Of 503 PWID, 60% currently owned naloxone. In the past 12\u2009months, 74% witnessed an opioid overdose and 25% experienced one. Those who experienced current homelessness were less likely to own naloxone (aPR: 0.79; 95% CI: 0.68, 0.91), as were those who had been recently incarcerated (aPR: 0.83; 95% CI: 0.71, 0.97). Respondents who reported recent known or possible fentanyl use were more likely to own naloxone (aPR: 1.23; 95% CI: 1.07, 1.43) as were those who experienced an opioid overdose in the past 12\u2009months (aPR: 1.33; 95% CI: 1.15, 1.53). Conclusions: The prevalence of naloxone ownership among PWID in NYC was high, potentially due to widespread community naloxone distribution programs; however, gaps in naloxone ownership existed. Interventions that further ease access to naloxone, such as reclassifying naloxone as an over-the-counter medication and making it available \u201coff the shelf,\u201d should be considered. More research is needed to identify barriers to access, uptake, and sustained possession within this group to maximize the impact of naloxone distribution during the ongoing fentanyl wave of the opioid overdose epidemic.<\/jats:p>","DOI":"10.1080\/08897077.2022.2074597","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T15:52:26Z","timestamp":1653580346000},"page":"1172-1179","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":15,"title":["Gaps in Naloxone Ownership among People who Inject Drugs during the Fentanyl Wave of the Opioid Overdose Epidemic in New York City, 2018"],"prefix":"10.1177","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0423-6902","authenticated-orcid":false,"given":"Alexis V.","family":"Rivera","sequence":"first","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV, and STIs, Long Island City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1951-4151","authenticated-orcid":false,"given":"Michelle L.","family":"Nolan","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use, Prevention, Care and Treatment, Long Island City, New Yoork, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Paone","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Alcohol and Drug Use, Prevention, Care and Treatment, Long Island City, New Yoork, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6043-2468","authenticated-orcid":false,"given":"Sidney A.","family":"Carrillo","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV, and STIs, Long Island City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Braunstein","sequence":"additional","affiliation":[{"name":"New York City Department of Health and Mental Hygiene, Bureau of Hepatitis, HIV, and STIs, Long Island City, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2022,1,1]]},"reference":[{"key":"bibr1-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4"},{"key":"bibr2-08897077.2022.2074597","author":"Centers for Disease Control and Prevention","year":"2018","journal-title":"Health Alert Network"},{"key":"bibr3-08897077.2022.2074597","unstructured":"New York City Department of Health and Mental Hygiene. Presence of fentanyl in cocaine contributing to increase in drug overdose deaths. Health Advisory 2017; https:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/han\/advisory\/fentanyl-advisory10.pdf."},{"key":"bibr4-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6802a3"},{"key":"bibr5-08897077.2022.2074597","volume-title":"Unintentional Drug Poisoning (Overdose) Deaths in New York City in 2019","author":"Nolan ML","year":"2020"},{"key":"bibr6-08897077.2022.2074597","unstructured":"Centers for Disease Control and Prevention. Evidence-based strategies for preventing opioid overdose: What's working in the United States. 2018; http:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2018-evidence-based-strategies.pdf. Accessed July 13, 2021."},{"key":"bibr7-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1111\/add.15163"},{"key":"bibr8-08897077.2022.2074597","first-page":"1","volume":"17","author":"Cataife G","year":"2020","journal-title":"Subst Abus"},{"key":"bibr9-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020033"},{"key":"bibr10-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108412"},{"key":"bibr11-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108759"},{"key":"bibr12-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107581"},{"key":"bibr13-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108912"},{"key":"bibr14-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-021-00538-9"},{"key":"bibr15-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0230127"},{"key":"bibr16-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224686"},{"key":"bibr17-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.107743"},{"key":"bibr18-08897077.2022.2074597","first-page":"107356","volume":"2014","author":"Naumann RB","year":"2019","journal-title":"Drug Alcohol Depend"},{"key":"bibr19-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f174"},{"key":"bibr20-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6933a2"},{"key":"bibr21-08897077.2022.2074597","unstructured":"Dasgupta N, Doe Simkins M, Wheeler E. Opioid Safety and Naloxone Network Buyers Club: Restoring Naloxone. http:\/\/localhost\/files\/qr46r915r2021."},{"key":"bibr22-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.03.003"},{"key":"bibr23-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.1604"},{"key":"bibr24-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108127"},{"key":"bibr25-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112585"},{"key":"bibr26-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108088"},{"key":"bibr27-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227968"},{"key":"bibr28-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwr327"},{"key":"bibr29-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05779-1"},{"key":"bibr30-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2018.1442899"},{"key":"bibr31-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.08.004"},{"key":"bibr32-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.07.010"},{"key":"bibr33-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103253"},{"key":"bibr34-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-019-0145-5"},{"key":"bibr35-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1108\/IJPH-08-2016-0039"},{"key":"bibr36-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2017.11.029"},{"key":"bibr37-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1177\/1078345819882771"},{"key":"bibr38-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-015-0084-8"},{"key":"bibr39-08897077.2022.2074597","unstructured":"Anthony-North V, Pope LG, Pottingher S, Sederbaum I. Corrections-based responses to the opioid epidemic: lessons from New York State's overdose education and naloxone distribution program. 2018; https:\/\/www.vera.org\/downloads\/publications\/corrections-responses-to-opioid-epidemic-new-york-state.pdf."},{"key":"bibr40-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2018.07.003"},{"key":"bibr41-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2020.03.005"},{"key":"bibr42-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-019-00349-1"},{"key":"bibr43-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.japh.2017.01.013"},{"key":"bibr44-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.759"},{"key":"bibr45-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2019.07.008"},{"key":"bibr46-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2019.07.006"},{"key":"bibr47-08897077.2022.2074597","unstructured":"New York City Department of Health and Mental Hygiene. Health Department Launches Citywide Fentanyl Awareness Campaign. [Press Release]. 2019; https:\/\/www1.nyc.gov\/site\/doh\/about\/press\/pr2019\/health-department-launches-fentanyl-awareness-campaign.page."},{"key":"bibr48-08897077.2022.2074597","unstructured":"New York City Department of Health and Mental Hygiene. Increase in drug overdoses deaths and increased presence of fentanyl in New York City. Health Advisory 2016; https:\/\/www1.nyc.gov\/assets\/doh\/downloads\/pdf\/han\/advisory\/fentanyl-overdose.pdf."},{"key":"bibr49-08897077.2022.2074597","unstructured":"New York City Department of Health and Mental Hygiene. Health department conducts public outreach to warn New Yorkers about the dangers of fentanyl. [Press release]. 2017; https:\/\/www1.nyc.gov\/site\/doh\/about\/press\/pr2017\/pr037-17.page."},{"key":"bibr50-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.06.004"},{"key":"bibr51-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1136\/jech-2019-212915"},{"key":"bibr52-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107923"},{"key":"bibr53-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2018.304845"},{"key":"bibr54-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2019.305202"},{"key":"bibr55-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103298"},{"key":"bibr56-08897077.2022.2074597","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2021.103513"},{"key":"bibr57-08897077.2022.2074597","unstructured":"Centers for Disease Control and Prevention. Influx of fentanyl-laced counterfeit pills and toxic fentanyl-related compounds further increases risk of fentanyl-related overdose and fatalities. Health Alert Network 2016; https:\/\/emergency.cdc.gov\/han\/han00395.asp."}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2022.2074597","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2022.2074597","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2022.2074597","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:56:49Z","timestamp":1777625809000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2022.2074597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["10.1080\/08897077.2022.2074597"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2022.2074597","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]}}}